Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
In a lawsuit that received little attention toward the end of last year, Regeneron has taken Sanofi to court over claims that its marketing and development partner violated the terms of a long-standing Dupixent collaboration. Regeneron disclosed the lawsuit in an annual filing this week.
In a lawsuit that received little attention toward the end of last year, Regeneron has taken Sanofi to court over claims that its marketing and development partner violated the terms of a long-standing Dupixent collaboration. Regeneron disclosed the lawsuit in an annual filing this week.
